It is noted that the decision to "recommend the predominant use of persons over 60 years of age" was made a few hours after the European Medicines Agency (EMA) confirmed the link after vaccination with AstraZeneca and the formation of blood clots.
However, according to Locatelli, thrombosis data are associated with the administration of only the first dose of AstraZeneca vaccine. Therefore, people under the age of 60 should not have difficulty obtaining the second and last dose of this drug.
As reported, on Wednesday, April 7, the European Medicines Agency concluded that between AstraZeneca and rare blood clots possible connection.
According to the regulator, cases of thrombosis are extremely rare, but the possible formation of blood clots should be included in the list of rare side effects after vaccination with AstraZeneca. At the same time, the EMA assured that the benefits of the vaccine far outweigh the possible risks.
Several countries, including Spain, the Philippines and South Korea, have already restricted the use of AstraZeneca to people under 60 years of age.
Found an error? Highlight the text and press
Subscribe to our Telegram channelto be the first to learn the latest news of Volyn, Ukraine and the world